Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283296 · ClinicalTrials.gov registry record · Phase 2
Development of a Collapsible Folding Manual Wheelchair
A Phase 2 study of Wheelchair Users, sponsored by VA Pittsburgh Healthcare System.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT00283296 is a Phase 2 study of Wheelchair Users that has completed, run by VA Pittsburgh Healthcare System. The registered enrollment target is 14 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00283296, a Phase 2 study of Wheelchair Users, has completed, sponsored by VA Pittsburgh Healthcare System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate the Endeavor, a compact, forward-folding, ultralight manual wheelchair that incorporates small "swing-down" wheels for navigation in confined areas. This enables access to narrow environments such as those encountered in offices, restrooms, and transportation settings. When using the small access wheels, the wheelchair also fits down the aisle of airplanes and collapses to be stowed in the overhead compartment. It is anticipated that the Endeavor will maximize mobility; increase access to confined areas; and ease the demands of travel for people with disabilities.
Conditions Studied
Interventions
- DEVICE Endeavor
Study Locations (1)
Pennsylvania
- Human Engineering Research Laboratories - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2004-01 |
| Est. Completion | 2011-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00283296
The ClinicalTrials.gov registry entry for NCT00283296 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Pittsburgh Healthcare System, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Wheelchair Users appearing as the primary indexed condition, and to 1 intervention - of which Endeavor is the first listed.
NCT00283296 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00283296 about?
NCT00283296 is a clinical study titled "Development of a Collapsible Folding Manual Wheelchair". The purpose of this research study is to evaluate the Endeavor, a compact, forward-folding, ultralight manual wheelchair that incorporates small "swing-down" wheels for navigation in confined areas. This enables access to narrow environments such as those encountered in offices, restrooms, and trans...
What is the current status of trial NCT00283296?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2004-01. Estimated completion is 2011-04.
What conditions does trial NCT00283296 study?
This clinical trial studies the following conditions: Wheelchair Users.
What interventions are being tested in trial NCT00283296?
The interventions under investigation include: Endeavor (DEVICE).
Who is sponsoring clinical trial NCT00283296?
This trial is sponsored by VA Pittsburgh Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00283296 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.